mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for ANXA8
Gene summary
Basic gene Info.Gene symbolANXA8
Gene nameannexin A8
SynonymsANX8
CytomapUCSC genome browser: 10q11.22
Type of geneprotein-coding
RefGenesNM_001040084.2,
NM_001271702.1,NM_001271703.1,
DescriptionVAC-betaannexin VIIIannexin-8vascular anticoagulant-beta
Modification date20141222
dbXrefs MIM : 602396
HGNC : HGNC
Ensembl : ENSG00000265190
Vega : OTTHUMG00000188209
ProteinUniProt: P13928
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_ANXA8
BioGPS: 653145
PathwayNCI Pathway Interaction Database: ANXA8
KEGG: ANXA8
REACTOME: ANXA8
Pathway Commons: ANXA8
ContextiHOP: ANXA8
ligand binding site mutation search in PubMed: ANXA8
UCL Cancer Institute: ANXA8
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:1900004negative regulation of serine-type endopeptidase activity2530088
GO:1900138negative regulation of phospholipase A2 activity2530088


Top
Ligand binding site mutations for ANXA8
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
D310E309DLUSC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for ANXA8
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
D310E309D-1.1013366
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for ANXA8 from PDB

Top
Differential gene expression and gene-gene network for ANXA8
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of ANXA8 and the right PPI network was created from samples without mutations in the LBS of ANXA8. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for ANXA8
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for ANXA8
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of ANXA8 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
CACALCIUM(2+)1w3wAD310


Top
Conservation information for LBS of ANXA8
Multiple alignments for P13928 in multiple species
LBSAA sequence# speciesSpecies
A269YAMKGAGTRDG4Homo sapiens, Homo sapiens, Pan troglodytes, Mus musculus
A269FAMKGAGTLDG1Bos taurus
A269YAMKGAGTLDG1Rattus norvegicus
D310SMIMEDTSGDY4Homo sapiens, Homo sapiens, Pan troglodytes, Bos taurus
D310SMIMADTSGYY1Mus musculus
D310SMIMGDTSGYY1Rattus norvegicus
G268YYAMKGAGTRD4Homo sapiens, Homo sapiens, Pan troglodytes, Mus musculus
G268YFAMKGAGTLD1Bos taurus
G268YYAMKGAGTLD1Rattus norvegicus
G270AMKGAGTRDGT4Homo sapiens, Homo sapiens, Pan troglodytes, Mus musculus
G270AMKGAGTLDGT2Bos taurus, Rattus norvegicus
M266RLYYAMKGAGT5Homo sapiens, Homo sapiens, Pan troglodytes, Mus musculus, Rattus norvegicus
M266RLYFAMKGAGT1Bos taurus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas